Linda P Powers, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 514 W Atlantic St, South Hill, VA 23970 Phone: 434-447-6969 Fax: 434-447-2240 |
News Archive
A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. The finding might lead to new therapies for a subset of patients with glioblastoma, the most common and lethal form of brain cancer.
An international team of researchers has taken a holistic approach to reveal for the first time where wildlife-human interfaces intersect with areas of poor human health outcomes and highly globalized cities, which could give rise to the next pandemic unless preventative measures are taken.
A Rochester, New York, researcher will receive a $263,622 grant to continue his study of injury to brain cell connections (synapses) in multiple sclerosis (MS) through the American Brain Foundation (formerly the American Academy of Neurology Foundation) and the National Multiple Sclerosis Society Clinician-Scientist Development Award.
Peter Blanck, Charles M. & Marion Kierscht Professor of Law at the University of Iowa and director of the Iowa Law, Health Policy and Disability Center, will testify before Congress this week on the lives of disabled people in America.
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute myeloid leukemia (AML).
› Verified 8 days ago